About
She earned a medical degree from Boston University's seven-year medical program, completed her internship and residency in internal medicine at Massachusetts General Hospital, and finished a nephrology fellowship through Massachusetts General Hospital and Brigham and Women's Hospital. She completed the Harvard Business School General Management Program. She held research and development leadership roles at Amgen, whose chairman and chief executive is Robert Bradway. Whoo also has a page for David Ricks, chair and chief executive of Eli Lilly and Company.
In its third-quarter 2026 earnings release, Vertex reported that it had closed its acquisition of Crinetics Pharmaceuticals.
Whoo compiled this page from public sources: Vertex SEC earnings release, 2 November 2026, The Conference Board, Wikipedia. It is not affiliated with or endorsed by Reshma Kewalramani. Are you Reshma Kewalramani? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17. Photo: Pacamah, CC BY 4.0, via Wikimedia Commons.
Want a page like this? Create yours from your résumé.
Experience
Chief Executive Officer and President — Vertex Pharmaceuticals
April 2020 – Present | Boston, Massachusetts
- Board member of Vertex
- Company closed its acquisition of Crinetics Pharmaceuticals in 2026
- Joined Vertex in 2017 as chief medical officer and executive vice president of global medicines development and medical affairs
- Trained in internal medicine and nephrology
Chief Medical Officer — Vertex Pharmaceuticals
From 2017